EMAIL US
U.S(TOLL FREE)
EAST COAST U.S.
GMT OFFICE HOURS
- Opportunity and Forecast, 2016 - 2025
Protein ingredients are produced from plant, dairy, and animal sources. They are applicable in personal care, cosmetics, food & beverages, and other applications. Plant-based sources for these ingredients include wheat, pea, soy, and others, whereas, egg, gelatin, egg isolates, and casein are animal sources. They are used in dietary supplements for development of muscles, increasing endurance and building strength, and injury recovery. Heavy metals, purity, and microbiological tests are conducted for protein ingredients before they are released for formulation. High demand for functional foods has resulted in increased awareness among consumers for protein ingredients.
Rise in health benefits, technological advancements, and growth in usage in novel applications drive the market growth. However, variation in soybean prices and rise in threat from soy-based products are factors that impede this growth. Growth in penetration in cosmetic and personal care products, owing to their health benefits, and technological innovations are expected to provide various opportunities in the industry.
The global protein ingredient market is segmented on the basis of product type, application, and geography. Based on product type, the market is bifurcated into plant and animal proteins. Applications covered in the study include food & beverages, infant formulations, personal care & cosmetics, and animal feed. Geographically, the market is analyzed across North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa.
Key manufacturers operating in this industry are DuPont, ADM, Bunge, Mead Johnson Scoular, Cargill, Roquette, NutraScience, Burcon, Rousselot, MGP Ingredients, and others. These players have implemented strategies, such as joint ventures, collaborations, new product launches, partnerships, joint ventures, expansion, mergers & acquisitions, and others, to strengthen their position in the global industry.
The global monoclonal antibody market was valued at $76,899 million in 2014 and is estimated to reach $214,922 million by 2025, registering a CAGR of 9.8% from 2018 to 2025. Read More >>